The DOI matches its Crossref record; 141 of the 141 references it cites were found in a registry or an index.
The IL-1β phenomena in neuroinflammatory diseases
Open accessAbstract
It is becoming increasingly clear that neuroinflammation has a causal role in the pathogenesis of central nervous system (CNS)-related diseases, and therefore therapeutic strategies targeting the regulation or availability of inflammatory mediators can be used to prevent or mitigate pathology. Interestingly, the proinflammatory cytokine, interleukin-1 beta (IL-1β), has been implicated in perpetuating immune responses and contributing to disease severity in a variety of CNS diseases ranging from multiple sclerosis, neurodegenerative diseases, traumatic brain injury, and diabetic retinopathy. Moreover, pharmacological blockade of IL-1 signaling has shown to be beneficial in some autoimmune and autoinflammatory diseases, making IL-1β a promising therapeutic target in neuroinflammatory conditions. This review highlights recent advances of our understanding on the multifaceted roles of IL-1β in neuroinflammatory diseases.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Neuroinflammation in Alzheimer's disease
Heneka, M. T., Carson, M. J., Khoury, J. E., Landreth, G. E., Brosseron, F., Feinstein, D. L., Jacobs, A. H., Wyss-Coray, T., Vitorica, J., Ransohoff, R. M., et al. (2015) · The Lancet Neurology · doi:10.1016/s1474-4422(15)70016-5 · Cited by 6,226
(2007) · Developments in Ophthalmology · doi:10.1159/isbn.978-3-318-01439-6 · Cited by 5,583
Fate Mapping Analysis Reveals That Adult Microglia Derive from Primitive Macrophages
Ginhoux, F., Greter, M., Leboeuf, M., Nandi, S., See, P., Gokhan, S., Mehler, M. F., Conway, S. J., Ng, L. G., Stanley, E. R., et al. (2010) · Science · doi:10.1126/science.1194637 · Cited by 5,175
IL-23 drives a pathogenic T cell population that induces autoimmune inflammation
Langrish, C. L., Chen, Y., Blumenschein, W. M., Mattson, J., Basham, B., Sedgwick, J. D., McClanahan, T., Kastelein, R. A., & Cua, D. J. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20041257 · Cited by 4,099 · cited 16×
“EAE disease can be independently mediated by adoptively transferring antigen-specific Th1 (Ando et al. 1989; Jäger et al. 2009; El-Behi et al. 2011) or Th17 (Langrish et al. 2005; Rangachari and Kuchroo 2013) cells.”
BackgroundInfluentialImmunological and inflammatory functions of the interleukin-1 family
Dinarello, C. A. (2009) · Annual Review of Immunology · doi:10.1146/annurev.immunol.021908.132612 · Cited by 3,466 · cited 1×
“…interleukin-1 (IL-1) family consist of 11 unique known ligands and antagonistic receptors (IL-1a and IL-1b, IL-18, IL-33, IL-36a, b, g, IL-1Ra, IL-36Ra, IL-38 and IL-37) which independently induce local and systemic inflamma- tion or induce anti-inflammatory responses (Dinarello 2009).”
BackgroundNLRP3 is activated in Alzheimer’s disease and contributes to pathology in APP/PS1 mice
Heneka, M. T., Kummer, M. P., Stutz, A., Delekate, A., Schwartz, S., Vieira-Saecker, A., Griep, A., Axt, D., Remus, A., Tzeng, T.-C., et al. (2013) · Nature · doi:10.1038/nature11729 · Cited by 2,898
The NLRP3 inflammasome instigates obesity-induced inflammation and insulin resistance
Vandanmagsar, B., Youm, Y.-H., Ravussin, A., Galgani, J. E., Stadler, K., Mynatt, R. L., Ravussin, E., Stephens, J. M., & Dixit, V. D. (2011) · Nature Medicine · doi:10.1038/nm.2279 · Cited by 2,655
The NALP3 inflammasome is involved in the innate immune response to amyloid-β
Halle, A., Hornung, V., Petzold, G. C., Stewart, C. R., Monks, B. G., Reinheckel, T., Fitzgerald, K. A., Latz, E., Moore, K. J., & Golenbock, D. T. (2008) · Nature Immunology · doi:10.1038/ni.1636 · Cited by 2,441
Interleukin-1 in the pathogenesis and treatment of inflammatory diseases
Dinarello, C. A. (2011) · Blood · doi:10.1182/blood-2010-07-273417 · Cited by 2,248
Immunopathology of multiple sclerosis
Dendrou, C. A., Fugger, L., & Friese, M. A. (2015) · Nature Reviews Immunology · doi:10.1038/nri3871 · Cited by 2,215
Immune attack: the role of inflammation in Alzheimer disease
Heppner, F. L., Ransohoff, R. M., & Becher, B. (2015) · Nature Reviews Neuroscience · doi:10.1038/nrn3880 · Cited by 2,134
Interleukin-1-receptor antagonist in type 2 diabetes mellitus
Larsen, C. M., Faulenbach, M., Vaag, A., Vølund, A., Ehses, J. A., Seifert, B., Mandrup-Poulsen, T., & Donath, M. Y. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa065213 · Cited by 1,798
Brain interleukin 1 and S-100 immunoreactivity are elevated in Down syndrome and Alzheimer disease.
Griffin, W. S., Stanley, L. C., Ling, C., White, L., MacLeod, V, Perrot, L. J., White, C. L., & Araoz, C. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.19.7611 · Cited by 1,777
Treating inflammation by blocking interleukin-1 in a broad spectrum of diseases
Dinarello, C. A., Simon, A., & van der Meer, J. W. M. (2012) · Nature Reviews Drug Discovery · doi:10.1038/nrd3800 · Cited by 1,768
Multiple Sclerosis: An Immune or Neurodegenerative Disorder?
Trapp, B. D., & Nave, K.-A. (2008) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.30.051606.094313 · Cited by 1,724
Fatty acid–induced NLRP3-ASC inflammasome activation interferes with insulin signaling
Wen, H., Gris, D., Lei, Y., Jha, S., Zhang, L., Huang, M. T.-H., Brickey, W. J., & Ting, J. P.-Y. (2011) · Nature Immunology · doi:10.1038/ni.2022 · Cited by 1,698
Antonetti, D. A., Klein, R., & Gardner, T. W. (2012) · New England Journal of Medicine · doi:10.1056/nejmra1005073 · Cited by 1,659
Integrated Systems Approach Identifies Genetic Nodes and Networks in Late-Onset Alzheimer’s Disease
Zhang, B., Gaiteri, C., Bodea, L.-G., Wang, Z., McElwee, J., Podtelezhnikov, A. A., Zhang, C., Xie, T., Tran, L., Dobrin, R., et al. (2013) · Cell · doi:10.1016/j.cell.2013.03.030 · Cited by 1,657
The Inflammasome NLRs in Immunity, Inflammation, and Associated Diseases
Davis, B. K., Wen, H., & Ting, J. P.-Y. (2011) · Annual Review of Immunology · doi:10.1146/annurev-immunol-031210-101405 · Cited by 1,618
Microglia and inflammation-mediated neurodegeneration: Multiple triggers with a common mechanism
Block, M. L., & Hong, J.-S. (2005) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2005.06.004 · Cited by 1,557
Microglia emerge from erythromyeloid precursors via Pu.1- and Irf8-dependent pathways
Kierdorf, K., Erny, D., Goldmann, T., Sander, V., Schulz, C., Perdiguero, E. G., Wieghofer, P., Heinrich, A., Riemke, P., Hölscher, C., et al. (2013) · Nature Neuroscience · doi:10.1038/nn.3318 · Cited by 1,457
Samad, T. A., Moore, K. A., Sapirstein, A., Billet, S., Allchorne, A., Poole, S., Bonventre, J. V., & Woolf, C. J. (2001) · Nature · doi:10.1038/35068566 · Cited by 1,281
Simard, A. R., Soulet, D., Gowing, G., Julien, J.-P., & Rivest, S. (2006) · Neuron · doi:10.1016/j.neuron.2006.01.022 · Cited by 1,265
Critical Regulation of Early Th17 Cell Differentiation by Interleukin-1 Signaling
Chung, Y., Chang, S. H., Martinez, G. J., Yang, X. O., Nurieva, R., Kang, H. S., Ma, L., Watowich, S. S., Jetten, A. M., Tian, Q., et al. (2009) · Immunity · doi:10.1016/j.immuni.2009.02.007 · Cited by 1,199
Codarri, L., Gyülvészi, G., Tosevski, V., Hesske, L., Fontana, A., Magnenat, L., Suter, T., & Becher, B. (2011) · Nature Immunology · doi:10.1038/ni.2027 · Cited by 1,191 · cited 1×
“Further EAE studies identified a critical role of IL1b and IL-23 in regulating the production of Th17-derived GM-CSF (transcribed from Csf2), a non-redundant cyto- kine required for T cells to become encephalitogenic (Codarri et al. 2011; El-Behi et al. 2011; Mufazalov et al. 2016).”
BackgroundT cell subsets and their signature cytokines in autoimmune and inflammatory diseases
Raphael, I., Nalawade, S., Eagar, T. N., & Forsthuber, T. G. (2015) · Cytokine · doi:10.1016/j.cyto.2014.09.011 · Cited by 1,160
Systemic inflammation and disease progression in Alzheimer disease
Holmes, C., Cunningham, C., Zotova, E., Woolford, J., Dean, C., Kerr, S., Culliford, D., & Perry, V. H. (2009) · Neurology · doi:10.1212/wnl.0b013e3181b6bb95 · Cited by 1,139
Inflammation in diabetic retinopathy
Tang, J., & Kern, T. S. (2011) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2011.05.002 · Cited by 1,116
Glucose-induced β cell production of IL-1β contributes to glucotoxicity in human pancreatic islets
Maedler, K., Sergeev, P., Ris, F., Oberholzer, J., Joller-Jemelka, H. I., Spinas, G. A., Kaiser, N., Halban, P. A., & Donath, M. Y. (2017) · Journal of Clinical Investigation · doi:10.1172/jci92172 · Cited by 1,114
Debris clearance by microglia: an essential link between degeneration and regeneration
Neumann, H., Kotter, M. R., & Franklin, R. J. M. (2008) · Brain · doi:10.1093/brain/awn109 · Cited by 1,111
El-Behi, M., Ciric, B., Dai, H., Yan, Y., Cullimore, M., Safavi, F., Zhang, G.-X., Dittel, B. N., & Rostami, A. (2011) · Nature Immunology · doi:10.1038/ni.2031 · Cited by 1,071 · cited 3×
“Further EAE studies identified a critical role of IL1b and IL-23 in regulating the production of Th17-derived GM-CSF (transcribed from Csf2), a non-redundant cyto- kine required for T cells to become encephalitogenic (Codarri et al. 2011; El-Behi et al. 2011; Mufazalov et al. 2016).”
BackgroundNucleotide sequence of human monocyte interleukin 1 precursor cDNA.
Auron, P. E., Webb, A. C., Rosenwasser, L. J., Mucci, S. F., Rich, A., Wolff, S. M., & Dinarello, C. A. (1984) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.81.24.7907 · Cited by 1,042
Dopamine controls systemic inflammation through inhibition of NLRP3 inflammasome
Yan, Y., Jiang, W., Liu, L., Wang, X., Ding, C., Tian, Z., & Zhou, R. (2015) · Cell · doi:10.1016/j.cell.2014.11.047 · Cited by 1,014
Sutton, C., Brereton, C., Keogh, B., Mills, K. H. G., & Lavelle, E. C. (2006) · The Journal of Experimental Medicine · doi:10.1084/jem.20060285 · Cited by 1,010
Type I Interferon Inhibits Interleukin-1 Production and Inflammasome Activation
Guarda, G., Braun, M., Staehli, F., Tardivel, A., Mattmann, C., Förster, I., Farlik, M., Decker, T., Du Pasquier, R. A., Romero, P., et al. (2011) · Immunity · doi:10.1016/j.immuni.2011.02.006 · Cited by 933
Fibrinogen as a key regulator of inflammation in disease
Davalos, D., & Akassoglou, K. (2012) · Seminars in Immunopathology · doi:10.1007/s00281-011-0290-8 · Cited by 922
Inflammasome adaptors and sensors: intracellular regulators of infection and inflammation
Mariathasan, S., & Monack, D. M. (2007) · Nature Reviews Immunology · doi:10.1038/nri1997 · Cited by 869
TREM2-mediated early microglial response limits diffusion and toxicity of amyloid plaques
Wang, Y., Ulland, T. K., Ulrich, J. D., Song, W., Tzaferis, J. A., Hole, J. T., Yuan, P., Mahan, T. E., Shi, Y., Gilfillan, S., et al. (2016) · Journal of Experimental Medicine · doi:10.1084/jem.20151948 · Cited by 840
Blum-Degena, D., Müller, T., Kuhn, W., Gerlach, M., Przuntek, H., & Riederer, P. (1995) · Neuroscience Letters · doi:10.1016/0304-3940(95)12192-7 · Cited by 801
Jäger, A., Dardalhon, V., Sobel, R. A., Bettelli, E., & Kuchroo, V. K. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0901906 · Cited by 783 · cited 17×
“EAE disease can be independently mediated by adoptively transferring antigen-specific Th1 (Ando et al. 1989; Jäger et al. 2009; El-Behi et al. 2011) or Th17 (Langrish et al. 2005; Rangachari and Kuchroo 2013) cells.”
BackgroundInfluentialMicroglia and neurodegeneration: The role of systemic inflammation
Cunningham, C. (2013) · Glia · doi:10.1002/glia.22350 · Cited by 769
The adhesion molecule and cytokine profile of multiple sclerosis lesions
Cannella, B., & Raine, C. S. (1995) · Annals of Neurology · doi:10.1002/ana.410370404 · Cited by 763
Microglia constitute a barrier that prevents neurotoxic protofibrillar Aβ42 hotspots around plaques
Condello, C., Yuan, P., Schain, A., & Grutzendler, J. (2015) · Nature Communications · doi:10.1038/ncomms7176 · Cited by 718
Cytokine networks in neuroinflammation
Becher, B., Spath, S., & Goverman, J. (2017) · Nature Reviews Immunology · doi:10.1038/nri.2016.123 · Cited by 697
Jay, T. R., Miller, C. M., Cheng, P. J., Graham, L. C., Bemiller, S., Broihier, M. L., Xu, G., Margevicius, D., Karlo, J. C., Sousa, G. L., et al. (2015) · Journal of Experimental Medicine · doi:10.1084/jem.20142322 · Cited by 682 · cited 2×
“The involvement of peripheral myeloid cells/macrophages in AD pathogenesis remains controversial (Simard et al. 2006; Heppner et al. 2015; Jay et al. 2015), especially in the context of cells expressing triggering receptor expressed on myeloid cells 2 (TREM2).”
BackgroundSohn, E. H., van Dijk, H. W., Jiao, C., Kok, P. H. B., Jeong, W., Demirkaya, N., Garmager, A., Wit, F., Kucukevcilioglu, M., van Velthoven, M. E. J., et al. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1522014113 · Cited by 682
Heterogeneity of CNS myeloid cells and their roles in neurodegeneration
Prinz, M., Priller, J., Sisodia, S. S., & Ransohoff, R. M. (2011) · Nature Neuroscience · doi:10.1038/nn.2923 · Cited by 674
The role of interleukin-1 in neuroinflammation and Alzheimer disease: an evolving perspective
Shaftel, S. S., Griffin, W. S. T., & O'Banion, M. K. (2008) · Journal of Neuroinflammation · doi:10.1186/1742-2094-5-7 · Cited by 565
Krady, J. K., Basu, A., Allen, C. M., Xu, Y., LaNoue, K. F., Gardner, T. W., & Levison, S. W. (2005) · Diabetes · doi:10.2337/diabetes.54.5.1559 · Cited by 529
Interleukin-1β Promotes Repair of the CNS
Mason, J. L., Suzuki, K., Chaplin, D. D., & Matsushima, G. K. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-18-07046.2001 · Cited by 502
The NLRP3 and NLRP1 inflammasomes are activated in Alzheimer’s disease
Saresella, M., La Rosa, F., Piancone, F., Zoppis, M., Marventano, I., Calabrese, E., Rainone, V., Nemni, R., Mancuso, R., & Clerici, M. (2016) · Molecular Neurodegeneration · doi:10.1186/s13024-016-0088-1 · Cited by 489
The Cytokine GM-CSF Drives the Inflammatory Signature of CCR2+ Monocytes and Licenses Autoimmunity
Croxford, A. L., Lanzinger, M., Hartmann, F. J., Schreiner, B., Mair, F., Pelczar, P., Clausen, B. E., Jung, S., Greter, M., & Becher, B. (2015) · Immunity · doi:10.1016/j.immuni.2015.08.010 · Cited by 484
Macrophages in inflammatory multiple sclerosis lesions have an intermediate activation status
Vogel, D. Y., Vereyken, E. J., Glim, J. E., Heijnen, P. D., Moeton, M., van der Valk, P., Amor, S., Teunissen, C. E., van Horssen, J., & Dijkstra, C. D. (2013) · Journal of Neuroinflammation · doi:10.1186/1742-2094-10-35 · Cited by 479
Kitazawa, M., Cheng, D., Tsukamoto, M. R., Koike, M. A., Wes, P. D., Vasilevko, V., Cribbs, D. H., & LaFerla, F. M. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1100620 · Cited by 473
The Ins2AkitaMouse as a Model of Early Retinal Complications in Diabetes
Barber, A. J., Antonetti, D. A., Kern, T. S., Reiter, C. E. N., Soans, R. S., Krady, J. K., Levison, S. W., Gardner, T. W., & Bronson, S. K. (2005) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.04-1340 · Cited by 472
Microglial phagocytosis of living photoreceptors contributes to inherited retinal degeneration
Zhao, L., Zabel, M. K., Wang, X., Ma, W., Shah, P., Fariss, R. N., Qian, H., Parkhurst, C. N., Gan, W., & Wong, W. T. (2015) · EMBO Molecular Medicine · doi:10.15252/emmm.201505298 · Cited by 445
Shaftel, S. S., Kyrkanides, S., Olschowka, J. A., Miller, J.-N. H., Johnson, R. E., & O’Banion, M. K. (2007) · Journal of Clinical Investigation · doi:10.1172/jci31450 · Cited by 433 · cited 1×
“These experimental models propose novel and intriguing mechanism of action of IL-1bmediated inflammation towards resolution of plaque accumulation as previously reported (Shaftel et al. 2007a, b; Matousek et al. 2012).”
MethodNLRP3 Deficiency Ameliorates Neurovascular Damage in Experimental Ischemic Stroke
Yang, F., Wang, Z., Wei, X., Han, H., Meng, X., Zhang, Y., Shi, W., Li, F., Xin, T., Pang, Q., et al. (2014) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.2013.242 · Cited by 422
Inhibition of IL-12/IL-23 signaling reduces Alzheimer's disease–like pathology and cognitive decline
vom Berg, J., Prokop, S., Miller, K. R., Obst, J., Kälin, R. E., Lopategui-Cabezas, I., Wegner, A., Mair, F., Schipke, C. G., Peters, O., et al. (2012) · Nature Medicine · doi:10.1038/nm.2965 · Cited by 416
Ryu, J. K., & McLarnon, J. G. (2009) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2008.00434.x · Cited by 406 · cited 2×
“blood–brain barrier, and allow extravasation of fibrinogen, a potent inducer of microglial activation, that triggers neurotoxicity (Davalos and Akassoglou 2012; Paul et al. 2007; Ryu and McLarnon 2009).”
BackgroundFormation and maintenance of Alzheimer's disease β-amyloid plaques in the absence of microglia
Grathwohl, S. A., Kälin, R. E., Bolmont, T., Prokop, S., Winkelmann, G., Kaeser, S. A., Odenthal, J., Radde, R., Eldh, T., Gandy, S., et al. (2009) · Nature Neuroscience · doi:10.1038/nn.2432 · Cited by 401
Sustained effects of interleukin-1 receptor antagonist treatment in type 2 diabetes
Larsen, C. M., Faulenbach, M., Vaag, A., Ehses, J. A., Donath, M. Y., & Mandrup-Poulsen, T. (2009) · Diabetes Care · doi:10.2337/dc09-0533 · Cited by 401
Demircan, N., Safran, B. G., Soylu, M., Ozcan, A. A., & Sizmaz, S. (2006) · Eye · doi:10.1038/sj.eye.6702138 · Cited by 395
Dror, E., Dalmas, E., Meier, D. T., Wueest, S., Thévenet, J., Thienel, C., Timper, K., Nordmann, T. M., Traub, S., Schulze, F., et al. (2017) · Nature Immunology · doi:10.1038/ni.3659 · Cited by 394
Ando, D. G., Clayton, J., Kono, D., Urban, J. L., & Sercarz, E. E. (1989) · Cellular Immunology · doi:10.1016/0008-8749(89)90117-2 · Cited by 391
IL-33 ameliorates Alzheimer's disease-like pathology and cognitive decline
Fu, A. K. Y., Hung, K.-W., Yuen, M. Y. F., Zhou, X., Mak, D. S. Y., Chan, I. C. W., Cheung, T. H., Zhang, B., Fu, W.-Y., Liew, F. Y., et al. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1604032113 · Cited by 369
Ye, L., Huang, Y., Zhao, L., Li, Y., Sun, L., Zhou, Y., Qian, G., & Zheng, J. C. (2013) · Journal of Neurochemistry · doi:10.1111/jnc.12263 · Cited by 363
Glucose-induced β cell production of IL-1β contributes to glucotoxicity in human pancreatic islets
Maedler, K., Sergeev, P., Ris, F., Oberholzer, J., Joller‐Jemelka, H. I., Spinas, G. A., Kaiser, N., Halban, P. A., & Donath, M. Y. (2002) · Journal of Clinical Investigation · doi:10.1172/jci15318 · Cited by 363
Du, Y., Veenstra, A., Palczewski, K., & Kern, T. S. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1314575110 · Cited by 335
Kanwar, M., Chan, P.-S., Kern, T. S., & Kowluru, R. A. (2007) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.06-1280 · Cited by 333
Inflammasome-independent regulation of IL-1-family cytokines
Netea, M. G., van de Veerdonk, F. L., van der Meer, J. W. M., Dinarello, C. A., & Joosten, L. A. B. (2015) · Annual Review of Immunology · doi:10.1146/annurev-immunol-032414-112306 · Cited by 326
Patel, N. S., Paris, D., Mathura, V., Quadros, A. N., Crawford, F. C., & Mullan, M. J. (2005) · Journal of Neuroinflammation · doi:10.1186/1742-2094-2-9 · Cited by 319
Paul, J., Strickland, S., & Melchor, J. P. (2007) · The Journal of Experimental Medicine · doi:10.1084/jem.20070304 · Cited by 319
Vincent, J. A., & Mohr, S. (2007) · Diabetes · doi:10.2337/db06-0427 · Cited by 298
Effects of Gevokizumab on Glycemia and Inflammatory Markers in Type 2 Diabetes
Cavelti-Weder, C., Babians-Brunner, A., Keller, C., Stahel, M. A., Kurz-Levin, M., Zayed, H., Solinger, A. M., Mandrup-Poulsen, T., Dinarello, C. A., & Donath, M. Y. (2012) · Diabetes Care · doi:10.2337/dc11-2219 · Cited by 294
Microglia actions in Alzheimer's disease
Prokop, S., Miller, K. R., & Heppner, F. L. (2013) · Acta Neuropathologica · doi:10.1007/s00401-013-1182-x · Cited by 291
Inoue, M., Williams, K. L., Gunn, M. D., & Shinohara, M. L. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1201836109 · Cited by 288
The pathogenic role of the inflammasome in neurodegenerative diseases
Freeman, L. C., & Ting, J. P. ‐. (2016) · Journal of Neurochemistry · doi:10.1111/jnc.13217 · Cited by 276
Interleukin‐1β promotes oligodendrocyte death through glutamate excitotoxicity
Takahashi, J. L., Giuliani, F., Power, C., Imai, Y., & Yong, V. W. (2003) · Annals of Neurology · doi:10.1002/ana.10519 · Cited by 256
Using EAE to better understand principles of immune function and autoimmune pathology
Rangachari, M., & Kuchroo, V. K. (2013) · Journal of Autoimmunity · doi:10.1016/j.jaut.2013.06.008 · Cited by 246
Shaftel, S. S., Carlson, T. J., Olschowka, J. A., Kyrkanides, S., Matousek, S. B., & O'Banion, M. K. (2007) · The Journal of Neuroscience · doi:10.1523/jneurosci.1418-07.2007 · Cited by 243
NLRP3 Inflammasome Inhibitor Ameliorates Amyloid Pathology in a Mouse Model of Alzheimer’s Disease
Yin, J., Zhao, F., Chojnacki, J. E., Fulp, J., Klein, W. L., Zhang, S., & Zhu, X. (2018) · Molecular Neurobiology · doi:10.1007/s12035-017-0467-9 · Cited by 232
Neutrophils Mediate Blood–Spinal Cord Barrier Disruption in Demyelinating Neuroinflammatory Diseases
Aubé, B., Lévesque, S. A., Paré, A., Chamma, É., Kébir, H., Gorina, R., Lécuyer, M.-A., Alvarez, J. I., De Koninck, Y., Engelhardt, B., et al. (2014) · The Journal of Immunology · doi:10.4049/jimmunol.1400401 · Cited by 231
Carson, M. J. (2002) · Glia · doi:10.1002/glia.10145 · Cited by 227
Interleukin-1 Regulates Proliferation and Differentiation of Oligodendrocyte Progenitor Cells
Vela, J. (2002) · Molecular and Cellular Neuroscience · doi:10.1006/mcne.2002.1127 · Cited by 223
Brain interleukin-1 beta in Alzheimer's disease and vascular dementia.
Cacabelos, R., Alvarez, X. A., Fernández‐Novoa, L., Franco, A., Mangues, R., Pellicer, À., & Nishimura, T. (1994) · PubMed · Cited by 212
GM‐CSF promotes proliferation of human fetal and adult microglia in primary cultures
Lee, S. C., Liu, W., Brosnan, C. F., & Dickson, D. W. (1994) · Glia · doi:10.1002/glia.440120407 · Cited by 209
Toll-like receptor (TLR) and inflammasome actions in the central nervous system
Hanamsagar, R., Hanke, M. L., & Kielian, T. (2012) · Trends in Immunology · doi:10.1016/j.it.2012.03.001 · Cited by 203
Gulen, M. F., Kang, Z., Bulek, K., Youzhong, W., Kim, T. W., Chen, Y., Altuntas, C. Z., Sass Bak-Jensen, K., McGeachy, M. J., Do, J.-S., et al. (2010) · Immunity · doi:10.1016/j.immuni.2009.12.003 · Cited by 199
The Role of Microglia in Diabetic Retinopathy
Grigsby, J. G., Cardona, S. M., Pouw, C. E., Muniz, A., Mendiola, A. S., Tsin, A. T. C., Allen, D. M., & Cardona, A. E. (2014) · Journal of Ophthalmology · doi:10.1155/2014/705783 · Cited by 196
Self-citationCaspase Activation in Retinas of Diabetic and Galactosemic Mice and Diabetic Patients
Mohr, S., Xi, X., Tang, J., & Kern, T. S. (2002) · Diabetes · doi:10.2337/diabetes.51.4.1172 · Cited by 195
Caspase-1 Regulates the Inflammatory Process Leading to Autoimmune Demyelination
Furlan, R., Martino, G., Galbiati, F., Poliani, P. L., Smiroldo, S., Bergami, A., Desina, G., Comi, G., Flavell, R., Su, M. S., et al. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.163.5.2403 · Cited by 194
Sheng, J. G., Mrak, R. E., & Griffin, W. S. T. (1997) · Acta Neuropathologica · doi:10.1007/s004010050664 · Cited by 190
Jacobs, C. A., Baker, P. E., Roux, E. R., Picha, K. S., Toivola, B., Waugh, S., & Kennedy, M. K. (1991) · The Journal of Immunology · doi:10.4049/jimmunol.146.9.2983 · Cited by 181
Lévesque, S. A., Paré, A., Mailhot, B., Bellver‐Landete, V., Kébir, H., Lécuyer, M., Alvarez, J. I., Prat, A., Vaccari, J. P. D. R., Keane, R. W., et al. (2016) · The Journal of Experimental Medicine · doi:10.1084/jem.20151437 · Cited by 181
Kelley, J. M., Hughes, L. B., & Bridges, S. L. (2008) · Journal of Neuroinflammation · doi:10.1186/1742-2094-5-1 · Cited by 179
Kohno, H., Chen, Y., Kevany, B. M., Pearlman, E., Miyagi, M., Maeda, T., Palczewski, K., & Maeda, A. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.448712 · Cited by 176
Young microglia restore amyloid plaque clearance of aged microglia
Daria, A., Colombo, A., Llovera, G., Hampel, H., Willem, M., Liesz, A., Haass, C., & Tahirovic, S. (2017) · The EMBO Journal · doi:10.15252/embj.201694591 · Cited by 174
Mandolesi, G., Musella, A., Gentile, A., Grasselli, G., Haji, N., Sepman, H., Fresegna, D., Bullitta, S., De Vito, F., Musumeci, G., et al. (2013) · Journal of Neuroscience · doi:10.1523/jneurosci.5369-12.2013 · Cited by 170
Bading, H. (2017) · The Journal of Experimental Medicine · doi:10.1084/jem.20161673 · Cited by 170
Rivera, J. C., Sitaras, N., Noueihed, B., Hamel, D., Madaan, A., Zhou, T. E., Honoré, J., Quiniou, C., Joyal, J., Hardy, P., et al. (2013) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.113.301331 · Cited by 165
Role of Interleukin-1β in the Development of Retinopathy in Rats: Effect of Antioxidants
Kowluru, R. A., & Odenbach, S. (2004) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.04-0633 · Cited by 164
T cell–intrinsic ASC critically promotes TH17-mediated experimental autoimmune encephalomyelitis
Martin, B. N., Wang, C., Zhang, C.-J., Kang, Z., Gulen, M. F., Zepp, J. A., Zhao, J., Bian, G., Do, J., Min, B., et al. (2016) · Nature Immunology · doi:10.1038/ni.3389 · Cited by 162
NLRP3 inflammasome activation is associated with proliferative diabetic retinopathy
Loukovaara, S., Piippo, N., Kinnunen, K., Hytti, M., Kaarniranta, K., & Kauppinen, A. (2017) · Acta Ophthalmologica · doi:10.1111/aos.13427 · Cited by 162
Martin, E., Boucher, C., Fontaine, B., & Delarasse, C. (2017) · Aging Cell · doi:10.1111/acel.12522 · Cited by 156
The NLRP3 Inflammasome is Involved in the Pathogenesis of Parkinson’s Disease in Rats
Mao, Z., Liu, C., Ji, S., Yang, Q., Ye, H., Han, H., & Xue, Z. (2017) · Neurochemical Research · doi:10.1007/s11064-017-2185-0 · Cited by 155
Viswanathan, S., Foulds, W. S., Luu, C. D., Ling, E., & Kaur, C. (2011) · The Journal of Pathology · doi:10.1002/path.2858 · Cited by 155
Cerani, A., Tetreault, N., Ménard, C., Lapalme, E., Patel, C. B., Sitaras, N., Beaudoin, F., Leboeuf, D., Guire, V. D., Binet, F., et al. (2013) · Cell Metabolism · doi:10.1016/j.cmet.2013.09.003 · Cited by 153
Arginase 1+ microglia reduce Aβ plaque deposition during IL-1β-dependent neuroinflammation
Cherry, J. D., Olschowka, J. A., & O’Banion, M. K. (2015) · Journal of Neuroinflammation · doi:10.1186/s12974-015-0411-8 · Cited by 152
Mellergård, J., Edström, M., Vrethem, M., Ernerudh, J., & Dahle, C. (2009) · Multiple Sclerosis Journal · doi:10.1177/1352458509355068 · Cited by 151
IL-1β is an innate immune sensor of microbial proteolysis
LaRock, C. N., Todd, J., LaRock, D. L., Olson, J., O’Donoghue, A. J., Robertson, A. A. B., Cooper, M. A., Hoffman, H. M., & Nizet, V. (2016) · Science Immunology · doi:10.1126/sciimmunol.aah3539 · Cited by 150
Yang, L., Costa, M. B. ́., & Gerhardinger, C. (2012) · PLoS ONE · doi:10.1371/journal.pone.0036949 · Cited by 139
CCR2 defines in vivo development and homing of IL-23-driven GM-CSF-producing Th17 cells
Kara, E. E., McKenzie, D. R., Bastow, C. R., Gregor, C. E., Fenix, K. A., Ogunniyi, A. D., Paton, J. C., Mack, M., Pombal, D. R., Seillet, C., et al. (2015) · Nature Communications · doi:10.1038/ncomms9644 · Cited by 136
de Jong, B. A., Huizinga, T. W. J., Bollen, E. L. E. M., Uitdehaag, B. M. J., Bosma, G. P. T., van Buchem, M. A., Remarque, E. J., Burgmans, A. C. S., Kalkers, N. F., Polman, C. H., et al. (2002) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(02)00056-5 · Cited by 136
Burger, D., Molnarfi, N., Weber, M. S., Brandt, K. J., Benkhoucha, M., Gruaz, L., Chofflon, M., Zamvil, S. S., & Lalive, P. H. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0812183106 · Cited by 135
Martin, D., & Near, S. L. (1995) · Journal of Neuroimmunology · doi:10.1016/0165-5728(95)00108-e · Cited by 133
Mechanisms of glutamate toxicity in multiple sclerosis: biomarker and therapeutic opportunities
Macrez, R., Stys, P. K., Vivien, D., Lipton, S. A., & Docagne, F. (2016) · The Lancet Neurology · doi:10.1016/s1474-4422(16)30165-x · Cited by 127
Vallejo, S., Rosas, E. P., Romacho, T., Villalobos, L. A., Peiró, C., & Sánchez‐Ferrer, C. F. (2014) · Cardiovascular Diabetology · doi:10.1186/s12933-014-0158-z · Cited by 125
Rossi, S., Motta, C., Studer, V., Macchiarulo, G., Volpe, E., Barbieri, F. R., Ruocco, G., Buttari, F., Finardi, A., Mancino, R., et al. (2014) · Molecular Neurodegeneration · doi:10.1186/1750-1326-9-56 · Cited by 116
Cytokine-producing microglia have an altered beta-amyloid load in aged APP/PS1 Tg mice
Babcock, A. A., Ilkjær, L., Clausen, B. H., Villadsen, B., Dissing-Olesen, L., Bendixen, A. T. M., Lyck, L., Lambertsen, K. L., & Finsen, B. (2015) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2015.03.006 · Cited by 107
Subretinal mononuclear phagocytes induce cone segment loss via IL-1β
Eandi, C. M., Charles‐Messance, H., Augustin, S., Dominguez, E., Lavalette, S., Forster, V., Hu, S. J., Siqueiros‐Márquez, L., Craft, C. M., Sahel, J., et al. (2016) · eLife · doi:10.7554/elife.16490 · Cited by 100
Hu, S. J., Calippe, B., Lavalette, S., Roubeix, C., Montassar, F., Housset, M., Levy, O., Delarasse, C., Pâques, M., Sahel, J., et al. (2015) · Journal of Neuroscience · doi:10.1523/jneurosci.3955-14.2015 · Cited by 95
Schiffenbauer, J., Streit, W. J., Butfiloski, E. J., Labow, M., Edwards, C. K., & Moldawer, L. L. (2000) · Clinical Immunology · doi:10.1006/clim.2000.4851 · Cited by 88
Matousek, S. B., Ghosh, S., Shaftel, S. S., Kyrkanides, S., Olschowka, J. A., & O’Banion, M. K. (2012) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-011-9331-2 · Cited by 86 · cited 2×
“These experimental models propose novel and intriguing mechanism of action of IL-1bmediated inflammation towards resolution of plaque accumulation as previously reported (Shaftel et al. 2007a, b; Matousek et al. 2012).”
MethodExpression of IL-1β in rhesus EAE and MS lesions is mainly induced in the CNS itself
Burm, S. M., Peferoen, L. A. N., Zuiderwijk-Sick, E. A., Haanstra, K. G., Hart, B. A. ‘., van der Valk, P., Amor, S., Bauer, J., & Bajramovic, J. J. (2016) · Journal of Neuroinflammation · doi:10.1186/s12974-016-0605-8 · Cited by 85
Cardona, S. M., Mendiola, A. S., Yang, Y.-C., Adkins, S. L., Torres, V., & Cardona, A. E. (2015) · ASN NEURO · doi:10.1177/1759091415608204 · Cited by 83
Self-citationAl-aryahi, S., Kamato, D., Getachew, R., Zheng, W., Potocnik, S. J., Cohen, N. D., Guidone, D., Osman, N., & Little, P. J. (2014) · Cardiovascular Diabetology · doi:10.1186/1475-2840-13-80 · Cited by 82
Tonade, D., Liu, H., & Kern, T. S. (2016) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.16-19859 · Cited by 81
Peelen, E., Damoiseaux, J. G. M. C., Muris, A., Knippenberg, S. A. M., Smolders, J., Hupperts, R., & Thewissen, M. M. (2014) · Molecular Immunology · doi:10.1016/j.molimm.2014.10.008 · Cited by 71
Stahel, M., Becker, M., Graf, N., & Michels, S. (2015) · Retina · doi:10.1097/iae.0000000000000701 · Cited by 68
Differential regulation of Abeta42-induced neuronal C1q synthesis and microglial activation.
Fan, R., & Tenner, A. J. (2005) · Journal of Neuroinflammation · doi:10.1186/1742-2094-2-1 · Cited by 63
Mendiola, A. S., Garza, R., Cardona, S. M., Mythen, S. A., Lira, S. A., Akassoglou, K., & Cardona, A. E. (2017) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2016.00303 · Cited by 62
Self-citationSeppi, D., Puthenparampil, M., Federle, L., Ruggero, S., Toffanin, E., Rinaldi, F., Perini, P., & Gallo, P. (2014) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2014.02.014 · Cited by 59
IL‐1 signaling is critical for expansion but not generation of autoreactive GM‐CSF+ Th17 cells
Mufazalov, I. A., Schelmbauer, C., Regen, T., Kuschmann, J., Wanke, F., Gabriel, L. A., Hauptmann, J., Müller, W., Pinteaux, E., Kurschus, F. C., et al. (2016) · The EMBO Journal · doi:10.15252/embj.201694615 · Cited by 59
Jiang, Y., Liu, L., Curtiss, E., & Steinle, J. J. (2017) · Mediators of Inflammation · doi:10.1155/2017/2860956 · Cited by 51
Effect of cyclosporin‐A on the blood–retinal barrier permeability in streptozotocin‐induced diabetes
do Carmo, A., Cunha-Vaz, J. G., Carvalho, A. P., & Lopes, M. C. (2000) · Mediators of Inflammation · doi:10.1080/09629350020025764 · Cited by 48
Lu, P., Li, L., Liu, G., Zhang, X., & Mukaida, N. (2009) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.08-2732 · Cited by 47
Scuderi, S., D’Amico, A. G., Federico, C., Saccone, S., Magro, G. G., Bucolo, C., Drago, F., & D’Agata, V. (2015) · Journal of Molecular Neuroscience · doi:10.1007/s12031-015-0505-x · Cited by 43
Kawana, N., Yamamoto, Y., Ishida, T., Saito, Y., Konno, H., Arima, K., & Satoh, J. (2013) · Clinical and Experimental Neuroimmunology · doi:10.1111/cen3.12068 · Cited by 34
Grebing, M., Nielsen, H. H., Fenger, C., Jensen, K. T., von Linstow, C. U., Clausen, B. H., Söderman, M., Lambertsen, K. L., Thomassen, M., Kruse, T. A., et al. (2015) · Glia · doi:10.1002/glia.22937 · Cited by 21
Retinal Failure in Diabetes: a Feature of Retinal Sensory Neuropathy
Gray, E. J., & Gardner, T. W. (2015) · Current Diabetes Reports · doi:10.1007/s11892-015-0683-5 · Cited by 18
Cited by
Microglia in the Retina: Roles in Development, Maturity, and Disease
Silverman, S. M., & Wong, W. T. (2018) · Annual Review of Vision Science · doi:10.1146/annurev-vision-091517-034425 · Cited by 346
NLRP3 inflammasome in neuroinflammation and central nervous system diseases
Xu, W., Huang, Y., & Zhou, R. (2025) · Cellular & Molecular Immunology · doi:10.1038/s41423-025-01275-w · Cited by 295
Neuroinflammation and Proinflammatory Cytokines in Epileptogenesis
Soltani Khaboushan, A., Yazdanpanah, N., & Rezaei, N. (2022) · Molecular Neurobiology · doi:10.1007/s12035-022-02725-6 · Cited by 262
Level of IL-6, TNF, and IL-1β and age-related diseases: a systematic review and meta-analysis
Tylutka, A., Walas, Ł., & Zembron-Lacny, A. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1330386 · Cited by 262
Elahi, F. M., Casaletto, K. B., La Joie, R., Walters, S. M., Harvey, D., Wolf, A., Edwards, L., Rivera‐Contreras, W., Karydas, A., Cobigo, Y., et al. (2020) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2019.09.004 · Cited by 255
Metadata
- Authors
- Mendiola, A. S., & Cardona, A. E.
- Venue
- Journal of Neural Transmission
- Published
- 2017-05-22
- Volume
- 125
- Issue
- 5
- Pages
- 781-795
- ISSN
- 0300-9564 (ISSN-L)
- 1435-1463
- OpenAlex
- W2619899589
- Cited by
- 303
- References
- 141
- FWCI
- 3.36
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.